Showing results (1-10 of 23) with videos related to
Sort By:
Pageof 3
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|November 5, 2018
Supply and demand for hemophilia treatments-Systems-based approaches to mitigate the riskJ M Stoffman, S Jackson, J TeitelAmerican Journal of Hematology|January 1, 1988
Intraarticular methylprednisolone therapy in hemophilic arthropathyR Shupak, J Teitel, M B Garvey, et al.Transfusion Science|May 7, 1998
Surveillance for factor VIII inhibitor development in the Canadian Hemophilia A population following the widespread introduction of recombinant factor VIII replacement therapyA R Giles, G E Rivard, J Teitel, et al.Transfusion|July 1, 1992
Absence of human T-lymphotropic virus types I and II infection in an Ontario hemophilia populationG Dekaban, M Inwood, D Waters, et al.Diagnostic and Clinical Immunology|January 1, 1987
Humoral and cellular immune abnormalities in adult hemophiliacs followed over a 2-year periodJ Freedman, R Mazaheri, S Read, et al.Thrombosis and Haemostasis|May 6, 1998
A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting factor VIII:C inhibitors in the haemophilia A population of Canada. Association of Hemophilia Centre Directors of Canada. Factor VIII/IX Subcommittee of Scientific and Standardization Committee of International Society on Thrombosis and HaemostasisA R Giles, B Verbruggen, G E Rivard, et al.Thrombosis and Haemostasis|January 23, 1992
Characterization of the original Christmas disease mutation (cysteine 206----serine): from clinical recognition to molecular pathogenesisS A Taylor, J Duffin, C Cameron, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|January 16, 2008
A prospective surveillance study of factor VIII inhibitor development in the Canadian haemophilia A population following the switch to a recombinant factor VIII product formulated with sucroseM Rubinger, D Lillicrap, G E Rivard, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|November 15, 2011
Low prevalence of inhibitor antibodies in the Canadian haemophilia populationK E Webert, G E Rivard, J Teitel, et al.American Journal of Hematology|March 12, 1998
Platelet activation induced by porcine factor VIII (Hyate:C)H Chang, M Mody, A H Lazarus, et al.Pageof 3